111 related articles for article (PubMed ID: 28468051)
1. [Immunohistochemistry provides genetic information on tumors].
Fang R; Wang XT; Xia QY; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):356-361. PubMed ID: 28468051
[No Abstract] [Full Text] [Related]
2. The utility of immunohistochemistry for providing genetic information on tumors.
Chan JK; Ip YT; Cheuk W
Int J Surg Pathol; 2013 Oct; 21(5):455-75. PubMed ID: 24065374
[TBL] [Abstract][Full Text] [Related]
3. [Genotypic analysis and immunohistochemistry in human cancers: conflicting or complementary information?].
Puisieux A
Ann Pathol; 2002 Apr; 22(2):93-5. PubMed ID: 12124489
[No Abstract] [Full Text] [Related]
4. Immunohistochemical Detection of NRASQ61R Mutation in Diverse Tumor Types.
Dias-Santagata D; Su Y; Hoang MP
Am J Clin Pathol; 2016 Jan; 145(1):29-34. PubMed ID: 26712868
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and classification of the small round-cell tumors of childhood.
Cohn SL
Am J Pathol; 1999 Jul; 155(1):11-5. PubMed ID: 10393830
[No Abstract] [Full Text] [Related]
6. Immunohistochemistry 2015: Protein correlates of molecular alterations and predictive testing.
Hornick JL
Semin Diagn Pathol; 2015 Sep; 32(5):323-4. PubMed ID: 26250936
[No Abstract] [Full Text] [Related]
7. Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays.
Mobasheri A; Airley R; Hewitt SM; Marples D
Int J Oncol; 2005 May; 26(5):1149-58. PubMed ID: 15809704
[TBL] [Abstract][Full Text] [Related]
8. [Immunochemistry and genotype analysis of tumors. Second part: What future for the molecular diagnosis of tumors?].
Soussi T
Ann Pathol; 2002 Apr; 22(2):113-20. PubMed ID: 12124492
[TBL] [Abstract][Full Text] [Related]
9. Estimated prevalence of hereditary cancers and the need for surveillance in a Norwegian county, Telemark.
Stormorken AT; Hoff G; Norstein J; Bowitz-Lothe IM; Hanslien E; Grindedal E; Møller P
Scand J Gastroenterol; 2006 Jan; 41(1):71-9. PubMed ID: 16373279
[TBL] [Abstract][Full Text] [Related]
10. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors.
Chang X; Han J
Mol Carcinog; 2006 Mar; 45(3):183-96. PubMed ID: 16355400
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemistry and genotype analysis of tumors. First part: Which future for the immunochemical diagnosis of cancer?].
Svrcek M; Sabourin JC
Ann Pathol; 2002 Apr; 22(2):102-12. PubMed ID: 12124491
[TBL] [Abstract][Full Text] [Related]
12. Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid.
van den Berg FM; Baas IO; Polak MM; Offerhaus GJ
Am J Pathol; 1993 Feb; 142(2):381-5. PubMed ID: 8434637
[TBL] [Abstract][Full Text] [Related]
13. Role of ancillary studies in fine-needle aspiration from selected tumors.
Schmitt F; Barroca H
Cancer Cytopathol; 2012 Jun; 120(3):145-60. PubMed ID: 22045615
[TBL] [Abstract][Full Text] [Related]
14. [Succinate dehydrogenase-deficient tumors--a novel mechanism of tumor formation].
Miettinen M
Duodecim; 2015; 131(22):2149-56. PubMed ID: 26749909
[TBL] [Abstract][Full Text] [Related]
15. FASAY: a simple functional assay in yeast for identification of p53 mutation in tumors.
Smardová J
Neoplasma; 1999; 46(2):80-8. PubMed ID: 10466430
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas.
Routhier CA; Mochel MC; Lynch K; Dias-Santagata D; Louis DN; Hoang MP
Hum Pathol; 2013 Nov; 44(11):2563-70. PubMed ID: 24071017
[TBL] [Abstract][Full Text] [Related]
17. [New types of analyses in clinical cytology improve diagnosis and treatment of tumors].
Stenkvist B
Lakartidningen; 1989 Aug; 86(32-33):2653. PubMed ID: 2550710
[No Abstract] [Full Text] [Related]
18. HLA class I antigen expression in human solid tumors.
Klein B; Levin I; Klein T
Isr J Med Sci; 1996 Dec; 32(12):1238-43. PubMed ID: 9007163
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
[TBL] [Abstract][Full Text] [Related]
20. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry.
Nenutil R; Smardova J; Pavlova S; Hanzelkova Z; Muller P; Fabian P; Hrstka R; Janotova P; Radina M; Lane DP; Coates PJ; Vojtesek B
J Pathol; 2005 Nov; 207(3):251-9. PubMed ID: 16161005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
